What peptides are, what the evidence actually shows, and what is approved, investigational or unregulated. Every Thursday: the week in peptide science and regulation, and one peptide explained properly — mechanism, studies, status, risks. Education only; never dosing, sourcing or protocols, and never medical advice.
AI Disclosure: This podcast is curated by Patrick but uses AI-generated voice synthesis for audio production.
Ep 8: Six unapproved peptides can be compounded in US pharmacies without an FDA safety finding.
Peptides Weekly
Six unapproved peptides can be compounded in US pharmacies without an FDA safety finding.
What You Need to Know: Six unapproved peptides can be compounded in US pharmacies without an FDA safety finding. Health and Human Services has said it will not enforce against licensed compounders of that set, even though the FDA's drug center opposed the idea. ...
Sources: bioxconomy.com (https://www.bioxconomy.com/policy/hhs-greenlights-sale-of-six-unapproved-peptides-despite-fda-guidance) · demokratis.co.id (https://demokratis.co.id/en/hhs-allows-unapproved-peptides) · finance.yahoo.com (https://finance.yahoo.com/news/datameds-ai-secures-supply-agreement-six-compounded-peptides-following-fda-advisory-committee-recommendations-120528814.html) · europepmc.org (https://europepmc.org/article/MED/42768825) · bioprocessintl.com (https://www.bioprocessintl.com/facilities-capacity/shilpa-medicare-invests-in-peptide-capacity-as-glp-1-demand-keeps-outrunning-supply) · boxinginsider.com (https://www.boxinginsider.com/training/six-peptides-from-our-january-guide-just-got-a-federal-green-light-licensed-fighters-still-cannot-touch-them/)
AI Disclosure: This podcast is curated by Patrick but uses AI-generated voice synthesis for audio production.
If this episode was useful, a rating or a short review on Apple Podcasts or Spotify is how the next listener finds the show — and following it in your app means the next episode is there when you are.
📝 Full show notes, transcript & sources: read the episode page (https://nerranetwork.com/blog/peptides/ep008.html?utm_source=podcast&utm_medium=episode&utm_campaign=nn-peptides-en-episode-ep008&utm_content=shownotes)
📬 Get the sources and notes by email, free: join the newsletter (https://nerranetwork.com/join.html?utm_source=podcast&utm_medium=episode&utm_campaign=nn-peptides-en-episode-ep008-join&utm_content=shownotes)
🌐 Part of the Nerra Network — explore every show at nerranetwork.com (https://nerranetwork.com).
29 Oct 2026
Ep 7: A coroner links a 75-year-old's cardiac arrest to CJC-1295 and ipamorelin.
Peptides Weekly
A coroner links a 75-year-old's cardiac arrest to CJC-1295 and ipamorelin.
What You Need to Know: A Victorian coroner has linked actor Richard Norton's cardiac arrest to two prescribed but unapproved peptides, CJC-1295 and ipamorelin, and asked Australia's regulator to reconsider whether doctors should be able to prescribe them. ...
Sources: theguardian.com (https://www.theguardian.com/australia-news/2026/oct/29/peptide-actor-richard-norton-death-coroner-tga-review-ntwnfb) · abc.net.au (https://www.abc.net.au/news/2026-10-29/victoria-peptide-death-coroners-report-richard-norton/107320590) · bbc.com (https://www.bbc.com/news/articles/cmq8nwd748v3o) · newsable.asianetnews.com (https://newsable.asianetnews.com/markets/hims-stock-jumps-5-after-hhs-temporarily-clears-compounding-of-six-peptides-articleshow-5g4gv33) · safemedicines.org (https://www.safemedicines.org/2026/10/statement-on-503a-peptide-enforcement.html) · news.ssbcrack.com (https://news.ssbcrack.com/hhs-plan-for-peptide-drug-access-faces-fda-opposition-amid-safety-concerns/) · statnews.com (https://www.statnews.com/2026/10/28/biotech-news-lillys-triple-g-drug-beats-ozempic-in-head-to-head-study/) · firstwordpharma.com (https://firstwordpharma.com/story/8314293)
AI Disclosure: This podcast is curated by Patrick but uses AI-generated voice synthesis for audio production.
If this episode was useful, a rating or a short review on Apple Podcasts or Spotify is how the next listener finds the show — and following it in your app means the next episode is there when you are.
📝 Full show notes, transcript & sources: read the episode page (https://nerranetwork.com/blog/peptides/ep007.html?utm_source=podcast&utm_medium=episode&utm_campaign=nn-peptides-en-episode-ep007&utm_content=shownotes)
📬 Get the sources and notes by email, free: join the newsletter (https://nerranetwork.com/join.html?utm_source=podcast&utm_medium=episode&utm_campaign=nn-peptides-en-episode-ep007-join&utm_content=shownotes)
🌐 Part of the Nerra Network — explore every show at nerranetwork.com (https://nerranetwork.com).
22 Oct 2026
Ep 6: Thirty-nine percent of GLP-1 users reported nail detachment, versus nine percent of controls.
Peptides Weekly
Thirty-nine percent of GLP-1 users reported nail detachment, versus nine percent of controls.
What You Need to Know: In a cross-sectional comparison presented at a dermatology congress, thirty-nine percent of GLP-1 users reported nail detachment, versus nine percent of people who had never taken the drugs. A separate surgical-record analysis linked the same drug class to slightly lower odds of combined heart and infection problems after planned operations. ...
Sources: labroots.com (https://www.labroots.com/trending/digestive-system/31257/glp-1-drugs-linked-nail-hair/amp) · yahoo.com (https://www.yahoo.com/news/science/articles/glp-1-drugs-linked-fewer-144330546.html) · safemedicines.org (https://www.safemedicines.org/2026/10/press-release-psm-petition-peptides.html) · statnews.com (https://www.statnews.com/2026/10/20/health-policy-news-bipartisan-group-of-lawmaker-urges-fda-to-close-peptide-loophole/) · news-medical.net (https://www.news-medical.net/news/20261021/Semaglutide-and-teduglutide-reduce-immune-driven-gut-injury-in-mice.aspx) · eewmagazineonline.com (https://www.eewmagazineonline.com/health-and-wellness/2026/10/20/tiktok-blocks-peptide-searches) · netimes.com.au (https://www.netimes.com.au/2026/10/20/peptide-surge-hits-nsw-hospitals/)
AI Disclosure: This podcast is curated by Patrick but uses AI-generated voice synthesis for audio production.
If this episode was useful, a rating or a short review on Apple Podcasts or Spotify is how the next listener finds the show — and following it in your app means the next episode is there when you are.
📝 Full show notes, transcript & sources: read the episode page (https://nerranetwork.com/blog/peptides/ep006.html?utm_source=podcast&utm_medium=episode&utm_campaign=nn-peptides-en-episode-ep006&utm_content=shownotes)
📬 Get the sources and notes by email, free: join the newsletter (https://nerranetwork.com/join.html?utm_source=podcast&utm_medium=episode&utm_campaign=nn-peptides-en-episode-ep006-join&utm_content=shownotes)
🌐 Part of the Nerra Network — explore every show at nerranetwork.com (https://nerranetwork.com).
15 Oct 2026
Ep 5: Three to four extra rare vision-loss cases per ten thousand showed up in an observational…
Peptides Weekly
Three to four extra rare vision-loss cases per ten thousand showed up in an observational GLP-1 study.
What You Need to Know: Three to four extra rare vision-loss cases per ten thousand showed up in an observational GLP-1 study. The link was seen in adults with type 2 diabetes and does not prove the drugs injured the optic nerve. ...
Sources: ua.news (https://ua.news/en/health/doslidzhennia-v-ssha-poviazalo-glp-1-z-ridkisnoiu-vtratoiu-zoru-sciencedaily) · sciencedaily.com (https://www.sciencedaily.com/releases/2026/10/261014015521.htm) · biospace.com (https://www.biospace.com/drug-development/verdiva-ends-mid-stage-study-of-oral-glp-1-amid-market-evolution) · medicaldaily.com (https://www.medicaldaily.com/fda-peptide-decision-bpc-157-harm-reports-las-vegas-intubations-479941) · bipc.com (https://www.bipc.com/fda-peptide-compounding-policy-what-a-temporary-enforcement-reprive-could-mean-for-pharmacies) · komu.com (https://www.komu.com/news/consumer/mu-health-care-physician-warns-against-use-of-unregulated-peptides/article_0274fbda-5d79-512d-94b1-fd3dc2aa4946.html)
AI Disclosure: This podcast is curated by Patrick but uses AI-generated voice synthesis for audio production.
If this episode was useful, a rating or a short review on Apple Podcasts or Spotify is how the next listener finds the show — and following it in your app means the next episode is there when you are.
📝 Full show notes, transcript & sources: read the episode page (https://nerranetwork.com/blog/peptides/ep005.html)
🌐 Part of the Nerra Network — explore every show at nerranetwork.com (https://nerranetwork.com).
8 Oct 2026
Ep 4: Unapproved peptides could reach temporary sale while treatment claims are still not fully…
Peptides Weekly
Unapproved peptides could reach temporary sale while treatment claims are still not fully safety tested.
What You Need to Know: Unapproved peptides could reach temporary sale while treatment claims are still not fully safety tested. Political Wire, quoting The Washington Post, describes a drafting process for previously restricted peptides, not a completed approval and not a patient trial. ...
Sources: washingtonpost.com (https://www.washingtonpost.com/health/2026/10/07/trump-administration-paving-way-temporary-sale-some-unapproved-peptides/) · stocktwits.com (https://stocktwits.com/news-articles/markets/equity/hims-fda-panel-4-peptides-martin-shkreli-short/cZZYKkgR7Uy) · ascopost.com (https://ascopost.com/news/october-2026/glp-1-receptor-agonist-use-linked-to-lower-colorectal-cancer-risk-in-patients-with-inflammatory-bowel-disease/) · amp.sacbee.com (https://amp.sacbee.com/entertainment/article317516843.html) · foodnavigator.com (https://www.foodnavigator.com/Article/2026/10/07/post-glp-1-weight-regain-mitigated-by-diet/)
AI Disclosure: This podcast is curated by Patrick but uses AI-generated voice synthesis for audio production.
If this episode was useful, a rating or a short review on Apple Podcasts or Spotify is how the next listener finds the show — and following it in your app means the next episode is there when you are.
📝 Full show notes, transcript & sources: read the episode page (https://nerranetwork.com/blog/peptides/ep004.html)
🌐 Part of the Nerra Network — explore every show at nerranetwork.com (https://nerranetwork.com).
1 Oct 2026
Ep 3: Nail detachment was over four times more common in people using GLP-1 drugs.
Peptides Weekly
Nail detachment was over four times more common in people using GLP-1 drugs.
What You Need to Know: A controlled study found nail detachment more than four times as often among people using GLP-1 drugs. The same week brought a muscle-loss trial beside semaglutide, a randomized look at how semaglutide meets the kidney, and two reminders that a population trend and a protein-design paper are not treatment results. ...
Sources: medicalxpress.com (https://medicalxpress.com/news/2026-09-detachment-common-glp-users.html) · reuters.com (https://www.reuters.com/business/healthcare-pharmaceuticals/regeneron-drug-halves-muscle-loss-combination-with-novos-semaglutide-trial-2026-09-30/) · nature.com (https://www.nature.com/articles/s41591-026-04674-2) · t.co (https://t.co/YrWo7z2VzG)
AI Disclosure: This podcast is curated by Patrick but uses AI-generated voice synthesis for audio production.
📝 Full show notes, transcript & sources: read the episode page (https://nerranetwork.com/blog/peptides/ep003.html)
🌐 Part of the Nerra Network — explore every show at nerranetwork.com (https://nerranetwork.com).
24 Sept 2026
Ep 2: Nearly one in six children taking GLP-1 drugs show nutritional deficiencies in a new study.
Peptides Weekly
Nearly one in six children taking GLP-1 drugs show nutritional deficiencies in a new study.
What You Need to Know: A retrospective analysis found nutritional deficiencies in almost 17 percent of children prescribed GLP-1 receptor agonists for weight loss or diabetes. The finding comes from claims data and highlights a measurable gap in monitoring for younger patients. ...
Sources: sciencedaily.com (https://www.sciencedaily.com/releases/2026/09/260923035926.htm) · yaledailynews.com (https://yaledailynews.com/articles/websites-help-glp-1-access-without-doctor-oversight-yale-study-finds) · euractiv.com (https://www.euractiv.com/news/sweden-sees-rise-in-reported-adverse-reactions-to-semaglutide/) · velo.outsideonline.com (https://velo.outsideonline.com/road/road-training/peptide-guide-for-cyclists/) · sciencedirect.com (https://www.sciencedirect.com/science/article/pii/S0196978126000598?dgcid=rss_sd_all) · europepmc.org (https://europepmc.org/article/MED/27633186)
AI Disclosure: This podcast is curated by Patrick but uses AI-generated voice synthesis for audio production.
📝 Full show notes, transcript & sources: read the episode page (https://nerranetwork.com/blog/peptides/ep002.html)
🌐 Part of the Nerra Network — explore every show at nerranetwork.com (https://nerranetwork.com).
23 Sept 2026
Ep 1: Phase 3 results for an investigational amylin peptide medicine in diabetes and obesity were…
Peptides Weekly
Phase 3 results for an investigational amylin peptide medicine in diabetes and obesity were released this week.
What You Need to Know: Novo Nordisk reported new phase 3 data on an amylin-based candidate. A pair of randomized trials found oral semaglutide did not slow progression in mild Alzheimer’s disease. ...
AI Disclosure: This podcast is curated by Patrick but uses AI-generated voice synthesis for audio production.
📝 Full show notes, transcript & sources: read the episode page (https://nerranetwork.com/blog/peptides/ep001.html)
🌐 Part of the Nerra Network — explore every show at nerranetwork.com (https://nerranetwork.com).
Contact Peptides Weekly
Guest appearances
Does not typically book guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
